SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sun Pharma signs US deal under MFN pricing to lower drug prices

Sun Pharmaceutical Industries signed a deal with the US government to lower prices of its innovative drugs in the US under the most favoured nation (MFN) pricing framework, aligned with the lowest prices paid by other developed nations.

SUNPHARMA

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories